Literature DB >> 25119683

Procalcitonin as a postmortem sepsis marker. A comparison of the validity of results obtained from blood serum, aqueous humour and cerebrospinal fluid.

S Schmidt1, M Windgassen, J-R Nofer, H Pfeiffer, S Ribbecke, A Schmeling.   

Abstract

In recent years, serum levels of the prohormone procalcitonin have been investigated in a number of studies in relation to postmortem sepsis diagnostics, as macroscopic and histomorphological findings are, as a rule, nonspecific. However, due to advanced haemolysis, it is often not possible to determine serum procalcitonin (PCT) levels in cases of sepsis-related death. Moreover, the impact of postmortem interval on PCT levels is largely unclarified. In view of this, the present pilot study investigated PCT levels in the serum, aqueous humour, and cerebrospinal fluid in a study population of 25 persons who died of sepsis and a control population of 25 deaths unrelated to sepsis. Using the Mann-Whitney U test, statistically significant differences in PCT levels were determined for all the analysed samples from the study and control populations. Logistic regression analysis was used to calculate cut-off values for sepsis diagnosis for all the sample types. Furthermore, the serum elimination rates published by Tsokos et al. (Int J Legal Med 114:237-243, 2001) were used to calculate the PCT levels at the time of death for the cases with a known postmortem interval. The results of our study demonstrate that, taking account of the postmortem elimination process, it is possible to infer the value at the time of death from the procalcitonin levels measured in all three sample types and to interpret this with the aid of a defined cut-off value. The findings need to be verified based on a larger study population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25119683     DOI: 10.1007/s00414-014-1057-2

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  17 in total

1.  Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis.

Authors:  B Müller; J C White; E S Nylén; R H Snider; K L Becker; J F Habener
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

2.  The use of rapid diagnostic test of procalcitonin serum levels for the postmortem diagnosis of sepsis.

Authors:  Frank Ramsthaler; Mattias Kettner; Gerhard Mall; Hansjuergen Bratzke
Journal:  Forensic Sci Int       Date:  2008-05-02       Impact factor: 2.395

3.  Kinetics of procalcitonin in iatrogenic sepsis.

Authors:  F M Brunkhorst; U Heinz; Z F Forycki
Journal:  Intensive Care Med       Date:  1998-08       Impact factor: 17.440

4.  Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities.

Authors:  Bettina Schrag; Pascale Roux-Lombard; Deborah Schneiter; Paul Vaucher; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2011-07-07       Impact factor: 2.686

5.  Serum procalcitonin levels in the postmortem diagnosis of sepsis.

Authors:  S Bode-Jänisch; S Schütz; A Schmidt; T Tschernig; A S Debertin; A Fieguth; L Hagemeier; J Teske; S Suerbaum; M Klintschar; F C Bange
Journal:  Forensic Sci Int       Date:  2013-02-19       Impact factor: 2.395

6.  Diagnostic value of lipopolysaccharide-binding protein and procalcitonin for sepsis diagnosis in forensic pathology.

Authors:  Marc Augsburger; Katia Iglesias; Daniel Bardy; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2012-10-13       Impact factor: 2.686

7.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

8.  Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study.

Authors:  Shahin Gaïni; Ole Graesbøll Koldkjaer; Court Pedersen; Svend Stenvang Pedersen
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

9.  Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.

Authors:  Canan BalcI; Hülya Sungurtekin; Ercan Gürses; Ugur Sungurtekin; Bünyamin Kaptanoglu
Journal:  Crit Care       Date:  2002-10-30       Impact factor: 9.097

10.  Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.

Authors:  Gian Paolo Castelli; Claudio Pognani; Michael Meisner; Antonio Stuani; Daniela Bellomi; Laura Sgarbi
Journal:  Crit Care       Date:  2004-06-10       Impact factor: 9.097

View more
  1 in total

1.  Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.

Authors:  Benjamin Ondruschka; Lina Woydt; Michael Bernhard; Heike Franke; Holger Kirsten; Sabine Löffler; Dirk Pohlers; Niels Hammer; Jan Dreßler
Journal:  Int J Legal Med       Date:  2018-08-30       Impact factor: 2.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.